新穎生醫股份有限公司 Approved
最後更新時間 2025/07/18 , 07:14 AM
最後更新時間 2025/07/18 , 07:14 AM
負責人
Ceng,Zi-Ling
統一編號
24613916
成立日期
2014/06/25
資本額
NT$1,000,000,000
實收資本額
NT$494,485,000
股票代號
6810
電話
03-5601816#201
地址
6-1F, No. 18, Taiyuan St., Zhubei City, Hsinchu County, 302, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Ceng,Zi-Ling Chairman 3.62%
Lin,Ting-Kuan Director 15.47% ANFU HEALTHCARE NO. 2 LIMITED PARTNERSHIP
Xu,Zhang-Li Director 0.42%
Wei,Yao-Hui Independent Director 0.00%
Shi,Fan-Quan Independent Director 0.00%
Zhang,Da-Ci Independent Director 0.00%
Huang,Qiong-Yu Independent Director 0.00%
營業項目
  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760999)
  • Data Processing, Hosting and Related Activities(631299)
  • Research and Experimental Development on Natural Sciences and Engineering(721000)
  • Miscellaneous Scientific Research and Development(723000)
  • 公司歷程
  • Change Person in Charge to Ceng,Zi-Ling
    2022/01/22
  • Change Person in Charge to Kai Yue,Zi-Chan-Guan-Li-You-Xian-Gong-Si
    2021/01/14
  • Change Capital to 1,000,000,000
    2017/08/04
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 12,297 1,208 2,177
    Operating cost 440 125 229
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 11,857 1,083 1,948
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 11,857 1,083 1,948
    Operating expenses 97,621 73,647 72,759
    Other gain (loss), net - - -
    Operating profit (loss) -85,764 -72,564 -70,811
    Non-operating income and expenses -1,795 -721 -129
    Net profit (loss) before tax -87,559 -73,285 -70,940
    Income tax expense (benefits) - - -
    Net profit (loss) of ongoing business for the current period -87,559 -73,285 -70,940
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -87,559 -73,285 -70,940
    Other comprehensive profit (loss), net - - -
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -87,559 -73,285 -70,940
    Net profit (loss) attributable to owners of parent company - - -
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company - - -
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) -2 -2 -2
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities - - -
    Net cash inflows (outflows) from investing activities - - -
    Net cash inflow (outflow) from financing activities - - -
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period - - -
    Beginning balance of cash and cash equivalents - - -
    Ending balance of cash and cash equivalents - - -
    項目 2024 2023 2022
    Current asset 366,378 93,951 95,070
    Non-current asset 163,327 170,706 178,047
    Total asset 529,705 264,657 273,117
    Current liability 20,914 18,467 19,116
    Non-current liability 101,701 106,262 113,462
    Total liability 122,615 124,729 132,578
    share capital 494,485 344,485 324,485
    Equity - secruity token - - -
    capital reserve 437,842 233,121 180,447
    retained earning -525,237 -437,678 -364,393
    Other equity - - -
    Treasury stock - - -
    Total equity attributable to owners of parent company - - -
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 407,090 139,928 140,539
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 8 4 4
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 遠腎佳檢測法DNlite
  • DNlite
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。